Apollon
PrivateLast Round
Seed
Apr 19, 2024
Total Funding Raised
$1.7M
Company Overview
Apollon is a medical technology company that develops a needle-free continuous glucose monitoring (CGM) device using Raman spectroscopy to track glucose levels non-invasively.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Clinical Trials
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apollon Comparables
Compare Apollon with similar companies based on industry and business-model similarity.
Apollon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 19, 2024 | ||||
| Seed | Nov 1, 2023 |
Key People
Founding team and executive leadership
Apollon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KB Investment | Seed |
| KB Investment | Seed |
| Behigh Investment | Seed |
| Mirae Science and Technology Holdings | Seed |
| STIC Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2024
$1.7M round led by Behigh Investment and KB Investment.
Apollon Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Apollon's valuation, stock price, and market status.